Statistically, the expression of SIGLEC-1 (molecules/monocyte) was not significantly increased in SSc patients compared with HCs (2097.94 ± 2134.39 vs. 1167.45 ± 380.93, p = 0.49; Figure 1A). This evidence concerns the gene SIGLEC1 and systemic sclerosis.